Shaghayegh Kamian

Shaghayegh Kamian

Auto-generated profile, based on publicly available information

Shaghayegh Kamian

Department of Radiation Oncology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2021 in Journal of the Egyptian National Cancer Institute
Verified
Journal Article
Open access
PDF file
AEAbdol Ali Ebrahimi
Abdol Ali Ebrahimi
HAHasan Ashoori
Hasan Ashoori
FVFarnaz Vahidian
Farnaz Vahidian
IMIman Samiei Mosleh
Iman Samiei Mosleh
SKShaghayegh Kamian
Shaghayegh Kamian
Background: Glioma is one of the most malignant brain tumors, accounting for about half of the gliomas that occur in central nervous system (CNS), originates from the glial tissue of the brain. The aim of the present study was to determine the expression levels of 5 lncRNAs (MDC1-AS1, HOXA11-AS, MALAT1, CASC2, ADAMTS9-AS2) in patients with high-grade glioma in comparison with low grade glioma. Methods: This was a retrospective study which determined molecular biomarker on pathologic glioma samples. We examined 100 patients’ pathologic block which consisted of 50 pathology samples of high-grade glioma (case group) and control group consisted of 50 pathology samples of low-grade glioma. This research was performed using real time polymerase chain reaction (PCR) technique. Results: The results showed that the expression of ADAMTS9-AS2 and HOXA11-AS genes significantly increased with increasing tumor grade. Also the expression of CASC2 gene significantly decreased with increasing tumor grade. Conclusions: It was concluded that ADAMTS9-AS2 and HOXA11-AS and CASC2 are promising lncRNA markers in prognosis of glioma.

22 August 2022 in Journal of the Egyptian National Cancer Institute
Verified
Journal Article
Open access
PDF file
HAHasan Ashoori
Hasan Ashoori
SKShaghayegh Kamian
Shaghayegh Kamian
FVFarnaz Vahidian
Farnaz Vahidian
MGMohammad Ebrahim Ghamarchehreh
Mohammad Ebrahim Ghamarchehreh
Introduction: Colorectal cancers (CRC) are among the most common cancers. There are different modalities for treatment including chemotherapy, surgery, and radiotherapy. There are some mutations in cancers which can assist in the treatment and better prognosis of patients. In this study, two molecular markers (miR-31 and miR-373) were involved in the pathogenesis of CRC and their association with histopathological features was investigated. As well, the prognostic value of these molecular markers was investigated in CRC patients with or without common KRAS mutations. Methods: Paraffin blocks of tissue samples from 150 patients who underwent colon surgery between 2018 and 2020 were prepared by the Pathology Department of Imam Hossein Hospital (Tehran, Iran). After DNA and RNA isolation, gene expression of miR-31 and miR-373 was determined using probe-based quantitative real-time polymerase chain reaction (qRT-PCR). Mutations of KRAS were surveyed using conventional PCR and agarose gel electrophoresis. Results: The mean age of the patients was 57.2 ± 13.4 years. KRAS codon 12 and 13 mutations were positive in 31 (20.6%) and 22 (14.6%) cases, respectively. The results showed that KRAS common mutations occurred in 32.6% of Iranian CRC patients. The expression levels of miR-31 and miR-373 increased in CRC patients with KRAS mutations in comparison with patients without these mutations. Conclusion: Considering the role of miR-31 and miR-373 in CRC tumor progression, it seems that the CRC patients bearing KRAS mutations have a poorer prognosis respective to patients without KRAS mutations.

9 March 2024 in Journal of Psychosocial Oncology
Verified
Journal Article
Closed access
NDNasrin Dadashi
Nasrin Dadashi
MPmarzieh pazokian
marzieh pazokian
NYNima Yadollahzade
Nima Yadollahzade
MTMahbobeh Taheri
Mahbobeh Taheri
SKShaghayegh Kamian
Shaghayegh Kamian
Death anxiety is a negative consequence of cancer that influences the quality of life of many patients. This study determined the predictors of death anxiety and the contribution of the sense of coherence to this disorder among Iranians with cancer. The present research was a descriptive-analytical study that examined cancer patients referring to one of the educational hospitals in Tehran, Iran. Two hundred eligible patients selected by purposeful sampling filled out a clinical and demographic questionnaire. The data were analyzed by the SPSS 20 software. The correlational results revealed a negative and significant relationship between death anxiety and a sense of coherence (r = -0.610). Likewise, age, gender, marital status, occupational and economic circumstances, and cancer type were among the variables that correlated with death anxiety and predicted 85% of this psychological state. The researchers recommend mental assessment in oncological care to identify psychological challenges to realize the ultimate goal of palliative care, i.e. improving patients' quality of life.

1 November 2025 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
SKShaghayegh Kamian
Shaghayegh Kamian
NHNaeimeh Hashemi
Naeimeh Hashemi
AMAhmad Mostaar
Ahmad Mostaar
ADAmir Bahador Yekeh Dehghan
Amir Bahador Yekeh Dehghan
FFForough Farkhondeh
Forough Farkhondeh
Background: This study aimed to compare the dose distribution and excess absolute risk (EAR) of secondary cancer risk for women with left breast cancer treated with mastectomy who were candidates for adjuvant radiotherapy between three-dimensional conformal radiotherapy (3D-CRT) and helical therapy (HT) techniques. Methods: For each patient planed with 3D-CRT, a plan was created for HT treatment, and data concluding maximum dose (Dmax), mean dose (Dmean), V5, V10, V20, and V30 were extracted from treatment planning systems. Organ equivalent dose (OED) and EAR were calculated based on the extracted data from dose-volume histogram (DVH). Results: In terms of Dmax, HT technique showed lower values for the heart, spinal cord, and ipsilateral lung compared to 3D-CRT technique. For the thyroid, esophagus, contralateral breast and lung, 3D-CRT technique yielded lower Dmax values. For Dmean, HT technique showed lower values only for the ipsilateral lung, while 3D-CRT technique produced lower values for the remaining organs. For V5, V10, V20, and V30, 3D-CRT technique generally exhibited lower values compared to HT technique, except the ipsilateral lung, where HT technique displayed lower values for V10, V20, and V30. For the heart, HT technique showed lower values for V20 and V30. As a result, HT technique resulted in higher OEDs and EARs for the contralateral breast and lung, while 3D-CRT technique produced higher OEDs and EARs for the ipsilateral lung. Conclusions: HT and 3D-CRT exhibit varying efficacies in treating breast cancer patients, with HT demonstrating superior outcomes for sparing the heart and ipsilateral lung, while 3D-CRT holds an edge in minimizing dose to the contralateral breast and lung. The choice of the most appropriate radiation therapy technique for a particular patient should be made on a case-by-case basis, respecting the risk of secondary cancer development, pneumonitis, radiation-induced cardiac events, age, overall health.

28 January 2019 in Reports of Radiotherapy and Oncology
Verified
Journal Article
Open access
PDF file
SKShaghayegh Kamian
Shaghayegh Kamian
AMAhmad Reza Zadeh Mafi
Ahmad Reza Zadeh Mafi
Reports of Radiotherapy and Oncology

27 August 2024 in International Journal of Cancer Management
Verified
Journal Article
Open access
PDF file
NDNasrin Dadashi
Nasrin Dadashi
MPmarzieh pazokian
marzieh pazokian
NYNima Yadollahzade
Nima Yadollahzade
SKShaghayegh Kamian
Shaghayegh Kamian
MTMahbobeh Taheri
Mahbobeh Taheri
MVMohamadmoeen Velayatimehr
Mohamadmoeen Velayatimehr
Background: The caregivers of cancer patients go through numerous changes in their lives, caused by the complexity of cancer care, which then influence their quality of life (QoL). In this context, the sense of coherence (SoC) has been introduced as individuals' capacity to adapt to complex situations. Objectives: This study aimed at examining the relationship between QoL and SoC among the caregivers of cancer patients. Methods: This descriptive correlational study was performed on the caregivers of cancer patients referred to a teaching hospital in Tehran, Iran. In total, 200 eligible caregivers, selected by purposive and convenience sampling from September to December 2022, completed the research instrument comprised of a researcher-made demographic-clinical information form, the SoC Scale (13-item), and WHOQoL-BREF. The data were analyzed by the SPSS 20 software. To investigate the relationship between caregivers’ SoC and QoL, first, the correlation was determined, and afterward, the significant variables were analyzed, using multiple linear regression. Results: The overall mean score of QoL among the caregivers was 52.12 ± 14.45. In this way, the highest and lowest values were associated with the domains of physical health and social relationships, receiving the mean scores of 55.19 ± 11.46 and 38.40 ± 10.08, respectively. The overall mean score of SoC was also equal to 49.71 ± 9.34. As well, the results of the study demonstrated a significant positive correlation between SoC and QoL (r = 0.585, P < 0.001) as well as its 3 domains. Considering the demographic and clinical factors, the regression outcomes revealed that SoC was a predictor of QoL in the caregivers of cancer patients (P < 0.001, Β = 0.65). Among the demographic factors, a significant correlation was accordingly observed between age, marital status, income level, employment status, and QoL and some of its domains (P < 0.05). Conclusions: It was argued that SoC could be a positive predictor and a protective factor for QoL among the caregivers of cancer patients. In this vein, it was recommended to give a boost to the SoC dimensions during oncology and palliative care via an interdisciplinary approach and a variety of interventions. Upon developing QoL in the caregivers, QoL among the cancer patients could be then promoted.